Affymetrix Inc., (Santa Clara, Calif.) leader of a consortium that last week was awarded a $31.5 million government grant to develop miniaturized DNA diagnostic systems, will focus on building high-tech tools for biomedical research and leave the development of clinical applications to its customers.

Affymetrix, a subsidiary of Affymax N.V. (AFMXF), uses photolithographic techniques and solid phase chemical synthesis to create arrays of DNA on microchips. The technology, called VLSIPS, allows for the detection and analysis of DNA sequences and expression.